Research Article
Antiproliferative, Apoptotic, and Autophagic Activity of Ranibizumab, Bevacizumab, Pegaptanib, and Aflibercept on Fibroblasts: Implication for Choroidal Neovascularization
Figure 5
Kinetics of cellular proliferation (a), mitotic activity (b), polykaryocytic index (c), and apoptosis (d) in L929 cells treated by bevacizumab at different concentrations (data shown are at Day 5 of the treatment; , ).
(a) |
(b) |
(c) |
(d) |